FRIBERG GREGORY R (EVP, Chief R&D Officer) reported 1 transaction at BIOMARIN PHARMACEUTICAL INC
Review the transaction codes below to understand the nature of each event.
Filed: 10/2/2025ACC: 0002038768-25-000007
Officer· EVP, Chief R&D Officer
Since Feb 2026
-3.30K
Net shares
Net seller
$178.9K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
3.30K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.30K
Price / share
$54.16
Trade value
$178.94K
% of position
7.1%
9/30/2025
46.81K→43.51K
Total
Net shares
−3.30K
Net value
-$178.94K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/30/2025 | F · Tax Withholding | −3.30K | $54.16 | $178.94K | 7.1% | 46.81K | 43.51K |
| Total | −3.30K | -$178.94K | ||||||
Derivative Transactions0
No derivative transactions reported